National Library of Medicine; Notice of Meeting, 3473 [08-158]

Download as PDF Federal Register / Vol. 73, No. 13 / Friday, January 18, 2008 / Notices is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; HB Conflict. Date: February 13, 2008. Time: 3 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Michele C. HindiAlexander, PhD, Division of Scientific Review, National Institutes of Health, National Institute for Child Health, and Human Development, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20812–7510, (301) 435–8382, hindialm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: January 11, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 08–159 Filed 1–17–08; 8:45 am] the Clinicaltrials.gov registry and the addition of a results database. It will consider new legislative mandates, in particular Public Law 110–85, and consult as necessary with relevant stakeholders and potential users of the ClinicalTrials.gov system to provide advice on initial implementation issues and longer-term strategies for enhancing the content and operation of the database. Name of Committee: Clinical Trials Working Group. Date: February 11, 2008. Time: 9 a.m. to 3 p.m. Agenda: To review clinical trials registration and results reporting. Place: National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20894. Contact Person: Christine Ireland, Committee Management Officer, National Library of Medicine, 6705 Rockledge Drive, Rockledge 1, Suite 301, Bethesda, MD 20892, 301–594–4929, irelanc@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Dated: January 11, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 08–158 Filed 1–17–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5186–N–03] BILLING CODE 4140–01–M Federal Property Suitable as Facilities To Assist the Homeless DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Office of the Assistant Secretary for Community Planning and Development, HUD. ACTION: Notice. National Institutes of Health rwilkins on PROD1PC63 with NOTICES National Library of Medicine; Notice of Meeting Notice is hereby given of the first Clinical Trials Working Group of the National Library of Medicine’s (NLM) Board of Regents. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The Working Group was established to advise the NLM Board of Regents on issues associated with the expansion of VerDate Aug<31>2005 16:37 Jan 17, 2008 Jkt 214001 SUMMARY: This Notice identifies unutilized, underutilized, excess, and surplus Federal property reviewed by HUD for suitability for possible use to assist the homeless. FOR FURTHER INFORMATION CONTACT: Kathy Ezzell, Department of Housing and Urban Development, 451 Seventh Street, SW., Room 7266, Washington, DC 20410; telephone (202) 708–1234; TTY number for the hearing- and speech-impaired (202) 708–2565 (these telephone numbers are not toll-free), or call the toll-free Title V information line at 800–927–7588. SUPPLEMENTARY INFORMATION: In accordance with 24 CFR part 581 and PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 3473 section 501 of the Stewart B. McKinney Homeless Assistance Act (42 U.S.C. 11411), as amended, HUD is publishing this Notice to identify Federal buildings and other real property that HUD has reviewed for suitability for use to assist the homeless. The properties were reviewed using information provided to HUD by Federal landholding agencies regarding unutilized and underutilized buildings and real property controlled by such agencies or by GSA regarding its inventory of excess or surplus Federal property. This Notice is also published in order to comply with the December 12, 1988 Court Order in National Coalition for the Homeless v. Veterans Administration, No. 88–2503– OG (D.D.C.). Properties reviewed are listed in this Notice according to the following categories: Suitable/available, suitable/ unavailable, suitable/to be excess, and unsuitable. The properties listed in the three suitable categories have been reviewed by the landholding agencies, and each agency has transmitted to HUD: (1) Its intention to make the property available for use to assist the homeless, (2) its intention to declare the property excess to the agency’s needs, or (3) a statement of the reasons that the property cannot be declared excess or made available for use as facilities to assist the homeless. Properties listed as suitable/available will be available exclusively for homeless use for a period of 60 days from the date of this Notice. Where property is described as for ‘‘off-site use only’’ recipients of the property will be required to relocate the building to their own site at their own expense. Homeless assistance providers interested in any such property should send a written expression of interest to HHS, addressed to John Hicks, Division of Property Management, Program Support Center, HHS, Room 5B–17, 5600 Fishers Lane, Rockville, MD 20857; (301) 443–2265. (This is not a toll-free number.) HHS will mail to the interested provider an application packet, which will include instructions for completing the application. In order to maximize the opportunity to utilize a suitable property, providers should submit their written expressions of interest as soon as possible. For complete details concerning the processing of applications, the reader is encouraged to refer to the interim rule governing this program, 24 CFR part 581. For properties listed as suitable/to be excess, that property may, if subsequently accepted as excess by GSA, be made available for use by the homeless in accordance with applicable E:\FR\FM\18JAN1.SGM 18JAN1

Agencies

[Federal Register Volume 73, Number 13 (Friday, January 18, 2008)]
[Notices]
[Page 3473]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-158]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Library of Medicine; Notice of Meeting

    Notice is hereby given of the first Clinical Trials Working Group 
of the National Library of Medicine's (NLM) Board of Regents.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.
    The Working Group was established to advise the NLM Board of 
Regents on issues associated with the expansion of the 
Clinicaltrials.gov registry and the addition of a results database. It 
will consider new legislative mandates, in particular Public Law 110-
85, and consult as necessary with relevant stakeholders and potential 
users of the ClinicalTrials.gov system to provide advice on initial 
implementation issues and longer-term strategies for enhancing the 
content and operation of the database.

    Name of Committee: Clinical Trials Working Group.
    Date: February 11, 2008.
    Time: 9 a.m. to 3 p.m.
    Agenda: To review clinical trials registration and results 
reporting.
    Place: National Library of Medicine, Building 38, Board Room, 
2nd Floor, 8600 Rockville Pike, Bethesda, MD 20894.
    Contact Person: Christine Ireland, Committee Management Officer, 
National Library of Medicine, 6705 Rockledge Drive, Rockledge 1, 
Suite 301, Bethesda, MD 20892, 301-594-4929, irelanc@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The comments should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person.

    Dated: January 11, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-158 Filed 1-17-08; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.